Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma.

2.50
Hdl Handle:
http://hdl.handle.net/10541/79123
Title:
Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma.
Authors:
Routledge, Jacqueline A; Burns, Meriel P; Swindell, Ric; Khoo, Vincent S; West, Catharine M L; Davidson, Susan E
Abstract:
PURPOSE: To examine the Late Effects Normal Tissue Task Force (LENT)-Subjective, Objective, Management, Analytic (SOMA) scales prospectively in carcinoma of the cervix treated curatively with radiotherapy (RT) using interviews and postal questionnaires and to test the sensitivity of the scales in assessing the radiation effects. METHODS AND MATERIALS: A consecutive series of 100 patients completed questionnaires to score the subjective part of the published LENT-SOMA scales. Assessments were made before RT and at approximately 21, 70, 200, 400, 600, and 800 days after the start of treatment. The acceptability and feasibility of using the scales was examined using compliance in completion of the questionnaires. The scales were validated by evaluating the concordance of data obtained by two independent scorers and by examining the ability of the scales to measure radiation-related symptoms. RESULTS: Questionnaires were completed for 89 patients before RT. The level of noncompliance was 11%. The concordance between scores when two people completed the questionnaires independently was excellent. Subjective subsite scores were highest 21 days after treatment but generally fell by 70 days. The average baseline overall LENT-SOMA subjective scores increased with advancing stage (p = 0.008) and were higher for patients treated with RT alone (p = 0.044). CONCLUSION: In cervical carcinoma, the LENT-SOMA scales were acceptable and feasible to administer in the clinic and appropriate in the measurement of early subjective morbidity from RT.
Affiliation:
Department of Clinical Oncology, Christie Hospital NHS Trust, Manchester, United Kingdom.
Citation:
Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. 2003, 56 (2):502-10 Int. J. Radiat. Oncol. Biol. Phys.
Journal:
International Journal of Radiation Oncology, Biology, Physics
Issue Date:
1-Jun-2003
URI:
http://hdl.handle.net/10541/79123
DOI:
10.1016/S0360-3016(02)04578-9
PubMed ID:
12738327
Type:
Article
Language:
en
ISSN:
0360-3016
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorRoutledge, Jacqueline A-
dc.contributor.authorBurns, Meriel P-
dc.contributor.authorSwindell, Ric-
dc.contributor.authorKhoo, Vincent S-
dc.contributor.authorWest, Catharine M L-
dc.contributor.authorDavidson, Susan E-
dc.date.accessioned2009-08-28T12:04:41Z-
dc.date.available2009-08-28T12:04:41Z-
dc.date.issued2003-06-01-
dc.identifier.citationEvaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. 2003, 56 (2):502-10 Int. J. Radiat. Oncol. Biol. Phys.en
dc.identifier.issn0360-3016-
dc.identifier.pmid12738327-
dc.identifier.doi10.1016/S0360-3016(02)04578-9-
dc.identifier.urihttp://hdl.handle.net/10541/79123-
dc.description.abstractPURPOSE: To examine the Late Effects Normal Tissue Task Force (LENT)-Subjective, Objective, Management, Analytic (SOMA) scales prospectively in carcinoma of the cervix treated curatively with radiotherapy (RT) using interviews and postal questionnaires and to test the sensitivity of the scales in assessing the radiation effects. METHODS AND MATERIALS: A consecutive series of 100 patients completed questionnaires to score the subjective part of the published LENT-SOMA scales. Assessments were made before RT and at approximately 21, 70, 200, 400, 600, and 800 days after the start of treatment. The acceptability and feasibility of using the scales was examined using compliance in completion of the questionnaires. The scales were validated by evaluating the concordance of data obtained by two independent scorers and by examining the ability of the scales to measure radiation-related symptoms. RESULTS: Questionnaires were completed for 89 patients before RT. The level of noncompliance was 11%. The concordance between scores when two people completed the questionnaires independently was excellent. Subjective subsite scores were highest 21 days after treatment but generally fell by 70 days. The average baseline overall LENT-SOMA subjective scores increased with advancing stage (p = 0.008) and were higher for patients treated with RT alone (p = 0.044). CONCLUSION: In cervical carcinoma, the LENT-SOMA scales were acceptable and feasible to administer in the clinic and appropriate in the measurement of early subjective morbidity from RT.en
dc.language.isoenen
dc.subjectCancer Stagingen
dc.subjectUterine Cervical Canceren
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshBrachytherapy-
dc.subject.meshEvaluation Studies as Topic-
dc.subject.meshFeasibility Studies-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshInterviews as Topic-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasm Staging-
dc.subject.meshOrgan Specificity-
dc.subject.meshProspective Studies-
dc.subject.meshQuestionnaires-
dc.subject.meshRadiation Injuries-
dc.subject.meshReproducibility of Results-
dc.subject.meshSeverity of Illness Index-
dc.subject.meshStatistics, Nonparametric-
dc.subject.meshUterine Cervical Neoplasms-
dc.titleEvaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Oncology, Christie Hospital NHS Trust, Manchester, United Kingdom.en
dc.identifier.journalInternational Journal of Radiation Oncology, Biology, Physicsen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.